Artificially intelligent proteomics improves cardiovascular risk assessment.
作者信息
Sze Siu Kwan
机构信息
School of Biological Sciences, Nanyang Technological University, Singapore.
出版信息
EBioMedicine. 2019 Feb;40:23-24. doi: 10.1016/j.ebiom.2019.01.014. Epub 2019 Jan 14.
Abstract
摘要
相似文献
1
Artificially intelligent proteomics improves cardiovascular risk assessment.人工智能蛋白质组学改善心血管风险评估。
EBioMedicine. 2019 Feb;40:23-24. doi: 10.1016/j.ebiom.2019.01.014. Epub 2019 Jan 14.
2
Identifying new Risk Markers and Potential Targets: The Value of the Proteome.识别新的风险标志物和潜在靶点：蛋白质组的价值。
Cardiovasc Drugs Ther. 2016 Feb;30(1):13-8. doi: 10.1007/s10557-016-6656-3.
3
Novel biomarkers for cardiovascular risk assessment: current status and future directions.心血管风险评估的新型生物标志物：现状与未来方向。
Future Cardiol. 2015 Sep;11(5):597-613. doi: 10.2217/fca.15.39. Epub 2015 Oct 7.
4
Proteomics landscape of radiation-induced cardiovascular disease: somewhere over the paradigm.辐射诱导心血管疾病的蛋白质组学全景：超越范式的某个地方。
Expert Rev Proteomics. 2017 Nov;14(11):987-996. doi: 10.1080/14789450.2017.1388743. Epub 2017 Oct 10.
5
Going -omics to identify novel therapeutic targets for cardiovascular disease.运用组学技术识别心血管疾病的新型治疗靶点。
EBioMedicine. 2019 Mar;41:7-8. doi: 10.1016/j.ebiom.2019.03.005. Epub 2019 Mar 14.
6
Biomarkers for cardiovascular risk assessment in autoimmune diseases.自身免疫性疾病中心血管风险评估的生物标志物。
Proteomics Clin Appl. 2015 Feb;9(1-2):48-57. doi: 10.1002/prca.201400125.
7
Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.心血管疾病中的蛋白质组学：最新进展、临床意义及应用
Expert Rev Proteomics. 2017 Feb;14(2):117-136. doi: 10.1080/14789450.2017.1274653. Epub 2017 Jan 5.
8
Proteomic Analysis of Blood Extracellular Vesicles in Cardiovascular Disease by LC-MS/MS Analysis.采用液相色谱-串联质谱分析法对心血管疾病患者血液细胞外囊泡进行蛋白质组学分析。
Methods Mol Biol. 2017;1619:141-149. doi: 10.1007/978-1-4939-7057-5_11.
9
Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.基于蛋白质组学的心血管疾病生物标志物开发：机制、临床及治疗见解
Mol Cell Proteomics. 2006 Oct;5(10):1853-64. doi: 10.1074/mcp.R600007-MCP200. Epub 2006 May 29.
10
Risk factors for cardiovascular disease: one down, many more to evaluate.心血管疾病的风险因素：已明确一个，还有更多需要评估。
Ann Intern Med. 1999 Jul 6;131(1):62-3. doi: 10.7326/0003-4819-131-1-199907060-00012.
引用本文的文献
1
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort.一种用于多民族和多种族 HIV+队列心血管疾病的蛋白质风险评分的推导。
J Am Heart Assoc. 2023 Jul 4;12(13):e027273. doi: 10.1161/JAHA.122.027273. Epub 2023 Jun 22.
2
Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression.基于先进质谱技术的蛋白质组学在研究缺氧驱动的癌症进展中的应用。
Front Oncol. 2021 Feb 23;11:559822. doi: 10.3389/fonc.2021.559822. eCollection 2021.
本文引用的文献
1
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease.靶向蛋白质组学对疑似冠心病患者冠状动脉斑块形态的预测价值。
EBioMedicine. 2019 Jan;39:109-117. doi: 10.1016/j.ebiom.2018.12.033. Epub 2018 Dec 23.
2
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.非传统危险因素心血管疾病风险评估：美国预防服务工作组建议声明。
JAMA. 2018 Jul 17;320(3):272-280. doi: 10.1001/jama.2018.8359.
3
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors.正常 LDL 胆固醇水平与无风险因素的亚临床动脉粥样硬化有关。
J Am Coll Cardiol. 2017 Dec 19;70(24):2979-2991. doi: 10.1016/j.jacc.2017.10.024.
4
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.细胞外囊泡在缺血性心脏病的诊断和治疗中的作用：欧洲心脏病学会心脏细胞生物学工作组立场文件。
Cardiovasc Res. 2018 Jan 1;114(1):19-34. doi: 10.1093/cvr/cvx211.
5
Monocyte adhesion to atherosclerotic matrix proteins is enhanced by Asn-Gly-Arg deamidation.单核细胞黏附在动脉粥样硬化基质蛋白上的能力通过天冬酰胺-甘氨酸-精氨酸去酰胺作用得到增强。
Sci Rep. 2017 Jul 18;7(1):5765. doi: 10.1038/s41598-017-06202-2.
6
Old Proteins in Man: A Field in its Infancy.人类体内的衰老蛋白质：一个尚处起步阶段的领域。
Trends Biochem Sci. 2016 Aug;41(8):654-664. doi: 10.1016/j.tibs.2016.06.004. Epub 2016 Jul 11.
7
Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.机器学习用于预测疑似冠心病患者的全因死亡率：一项为期5年的多中心前瞻性登记分析。
Eur Heart J. 2017 Feb 14;38(7):500-507. doi: 10.1093/eurheartj/ehw188.
8
Uncovering Neurodegenerative Protein Modifications via Proteomic Profiling.通过蛋白质组学分析揭示神经退行性疾病中的蛋白质修饰
Int Rev Neurobiol. 2015;121:87-116. doi: 10.1016/bs.irn.2015.06.002. Epub 2015 Jul 16.
9
Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?无症状受试者亚临床动脉粥样硬化筛查：我们能否进行，是否重要，以及我们是否应该进行？
J Am Coll Cardiol. 2010 Jul 6;56(2):98-105. doi: 10.1016/j.jacc.2009.09.081.
10
Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study.与冠心病发病相关的一些因素：弗雷明汉姆研究的六年随访经验
Am J Public Health Nations Health. 1959 Oct;49(10):1349-56. doi: 10.2105/ajph.49.10.1349.
Zotero 插件